Skip to content

PACS

PACS Group, Inc.

NYSE · USFinancial ServicesFinancial - Conglomerates
$44.73-3.03%

Price as of Jul 20, 2026

PACS growth

PACS Group, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+20.9%
EBITDA
+117.2%
EBIT
+165.3%
EPS
+246.8%
Free cash flow
-14.3%
Operating cash flow
+6.9%

Forward estimates

Revenue
+9.0%
EBITDA
+2.0%
EPS
+38.1%

Three-year CAGR

Revenue
+29.7%
EBITDA
+12.8%
EBIT
+10.5%
Net income
+8.4%
EPS
+7.1%
Free cash flow
+62.4%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.